Mark Rothera, Chief Commercial Officer at PTC THERAPEUTICS, INC. (PTCT), sold 9,700 shares at $58.75 ($563K) on 2015-01-13, disclosed to the SEC on 2015-01-15.
Scheduled sale ($563k) by Chief Commercial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $56.51 | 3,000 | $170K | 30.1% |
| 2 | $58.75 | 5,500 | $323K | 57.4% |
| 3 | $58.62 | 1,200 | $70K | 12.5% |
| Total | $58.04 avg | 9,700 | $563K | 100% |
| Filing → |
| PTCT | SELL | 2015-03-18 | $820K | — | Filing → |
| PTCT | SELL | 2015-03-13 | $23K | — | Filing → |
| PTCT | SELL | 2015-02-25 | $2.4M | — | Filing → |